Case number 1:21-cv-01061
Allergan USA, Inc. et al v. Alkem Laboratories Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 18, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per entry of D.I. 246 in Lead Civil Action 19-1727-RGA. (nms) |
| Oct 18, 2021 | 14 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179 B2. (Attachments: # (1) Order)(nms) |
| Oct 18, 2021 | 14 | Order (5) |
| Sep 14, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The filings at D.I. 14 (Answer), D.I. 15 (Disclosure Statement), and D.I. 16 (Motion for Pro Hac), have been removed. All filings are to be made in Lead Civil Action 19-1727-RGA ONLY (see D.I. [13]). (nms) |
| Aug 30, 2021 | 13 | Order (7) Docket Text: SO ORDERED Granting (D.I. 15 in 21-cv-1062-RGA; D.I. 12 in 21-cv-1064-RGA; D.I. 12 in 21-cv-1061-RGA; D.I. 225 in 19-cv-1727-RGA; D.I. 11 in 21-cv-1065-RGA; D.I. 13 in 21-cv-1066-RGA; D.I. 12 in 21-cv-1063-RGA) Stipulation and Proposed Order to Consolidate and Extend Time (*Reset Deadlines/Hearings: Joint Claim Construction Brief due by 12/3/2021, Pretrial Order due by 10/11/2022, Status letter due by 7/6/2022, A Bench Trial is set to start 11/7/2022, at 8:30 AM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2021. Associated Cases: 1:19-cv-01727-RGA et al.(nms) |
| Aug 27, 2021 | 12 | Main Document (7) Docket Text: STIPULATION and [Proposed] Order to Consolidate and Extend Time, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # (1) Letter)(Tigan, Jeremy) Modified on 8/30/2021 (nms). |
| Aug 27, 2021 | 12 | Letter to Judge Andrews (2) |
| Aug 20, 2021 | 11 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC: For Alkem Laboratories Limited waiver sent on 8/19/2021, answer due 10/18/2021. (Tigan, Jeremy) |
| Aug 17, 2021 | 9 | Main Document (8) Docket Text: FIRST Amended Complaint against Alkem Laboratories Limited - filed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. (Attachments: # (1) Exhibits A-B)(Tigan, Jeremy) Modified on 8/18/2021 (nms). |
| Aug 17, 2021 | 9 | Exhibits A-B (50) |
| Aug 17, 2021 | 10 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179 B2; 11,090,291 B2. (Tigan, Jeremy) Modified on 8/18/2021 (nms). |
| Aug 17, 2021 | 9 | Amended Complaint* (1) |
| Aug 10, 2021 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC: For Alkem Laboratories Limited waiver sent on 7/27/2021, answer due 9/27/2021. (Tigan, Jeremy) |
| Jul 29, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:21-cv-01061-RGA through 1:21-cv-01066-RGA (rjb) |
| Jul 28, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:21-cv-01061-LPS through 1:21-cv-01066-LPS (rjb) |
| Jul 28, 2021 | 7 | Letter (2) Docket Text: Letter to John A. Cerino, Clerk of the Court from Jeremy A. Tigan regarding Notice of Related Cases. (Tigan, Jeremy) |
| Jul 23, 2021 | 1 | Main Document (8) Docket Text: COMPLAINT filed against Alkem Laboratories Limited - Magistrate Consent Notice to Pltf. (Filing fee $402, receipt number ADEDC-3664619.) - filed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(kmd) |
| Jul 23, 2021 | 1 | Exhibit A (26) |
| Jul 23, 2021 | 1 | Civil Cover Sheet (1) |
| Jul 23, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Jul 23, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/2/2021. Date of Expiration of Patent: 3/14/2033.Thirty Month Stay Deadline: 1/2/2024. (kmd) |
| Jul 23, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179 B2. (kmd) |
| Jul 23, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (kmd) |
| Jul 23, 2021 | 6 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Alkem Laboratories Limited on 7/23/2021. (kmd) |
| Jul 23, 2021 | 1 | Complaint* (1) |
